Healty volunteers
Conditions
Interventions
Oral intake of test food for 8 weeks
Sponsors
MITSUBISHI GAS CHEMICAL COMPANY, INC.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Japanese men and women aged 20 to 65 2) Those who have been doing aerobic exercise for at least 30 minutes three times a week for at least six months 3) Healthy individuals who are not undergoing treatment for any illness or taking any medication 4) Those who wish to participate in clinical trials and can provide written informed consent 5) Those who can maintain a consistent daily lifestyle during the test period
Exclusion criteria
Exclusion criteria: 1) Those who have been taking medicines regularly within the last 3 months prior to the start of the study (excluding temporary medications such as painkillers and cold medicines) 2) Those with serious illnesses (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) or mental illnesses 3) Those with a history of serious illness (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) or digestive system disease 4) Those who have taken specific health foods, functional foods, health foods (including supplements), etc., more than three times a week within the three months prior to the start of the study, which may affect the study 5) Those who cannot stop taking foods for specified health uses, foods with functional claims, health foods (including supplements), etc. that may affect the study during the study period. 6) Those who are pregnant or breastfeeding, or who plan to or wish to do so during the study period 7) Those who drink a lot of alcohol (40g or more of pure alcohol per day on average) 8) Those with extremely irregular eating habits or those with irregular lifestyles such as working night shifts 9) Those with drug or food allergies 10) Those who have participated in a clinical trial regarding fatigue within 6 months of the start of the study 11)Those who are currently participating in a clinical trial of another drug or health food, have completed the trial within 4 weeks, or are scheduled to participate in another clinical trial while participating in this study. 12)Those who are deemed ineligible to participate in this study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate variability (HRV) after exercise | — |
Secondary
| Measure | Time frame |
|---|---|
| Pulse score after exercise load Body composition index Fatigue VAS | — |
Countries
Japan
Contacts
Public ContactTatsuo Uetake
CXwellness, Inc. Representative Directo
Outcome results
None listed